ong-term study of TA-650 in patients with psoriasis
Phase 3
- Conditions
- Psoriasis
- Registration Number
- JPRN-jRCT2080220314
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
[Inclusion criteria]
Psoriasis patients who are candidates for phototherapy or systemic therapy, 16 years and above, male and female.
[Exclusion criteria]
Patients who, have previously used any anti-TNFalpha therapy, have a history of serious infection which caused hospitalization within 6 months before the registration, have an active tuberculosis, have a complication or a history of malignancy within 5 years before the registration.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy (clinical response), Safety and Pharmacokinetics
- Secondary Outcome Measures
Name Time Method